1MT7 | Hydrolase Hydrolase Substrate | date | Sep 20, 2002 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Viability Of A Drug-Resistant Hiv-1 Protease Mutant: Structu Insights For Better Antiviral Therapy | ||||||||||||||
authors | M.Prabu-Jeyabalan, E.A.Nalivaika, N.M.King, C.A.Schiffer | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Protease Retropepsin Chain: A, B Synonym: Hiv-1 Protease Ec: 3.4.23.16 Engineered: Yes Mutation: Yes |
Organism_scientific: Human Immunodeficiency Virus 1 Organism_taxid: 11676 Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_strain: Tap106 Expression_system_vector_type: Plasmid Expression_system_plasmid: Pxc35-Pen18 | ||||||||||||||
Molecule: Substrate Analogue Chain: P Engineered: Yes Other_details: Ma-Ca Cleavage Site Of Hiv-1 Gag Polyprotein |
Synthetic: Yes Other_details: This Peptide Sequence Occurs Naturally In Ga | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.90 Å | ||||||||||||
ligand | ACT | enzyme | Hydrolase E.C.3.4.23.16 BRENDA | ||||||||||||
related structures | by homologous chain: 1BWA, 1W5X | ||||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Viability of a drug-resistant human immunodeficiency virus type 1 protease variant: structural insights for better antiviral therapy., Prabu-Jeyabalan M, Nalivaika EA, King NM, Schiffer CA, J Virol 2003 Jan;77(2):1306-15. PMID:12502847 |
Data retrieval |
View 1MT7 in 3D |
Visual 3D analysis of 1MT7 |
Structure-derived information |
- Domain d1mt7a_, region A [Jmol] [rasmolscript] [script source] - Domain d1mt7b_, region B [Jmol] [rasmolscript] [script source] |
Sequence-derived information |
Other resources with information on 1MT7 |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |